Cytokeratin Touted As Superior Marker For Detecting Biliary Tract Carcinoma

This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.

According to a study from the United States, the incidence of lymph node micrometastases in patients with biliary tract carcinoma is unknown. We evaluated the utility of three antibodies for immunohistochemical (IHC) detection of micrometastatic disease in patients with gallbladder and bile duct carcinoma.



You must be logged in to post comments.

We care about your feedback. Let us know how we can improve your CancerCompass experience.